Watertown, MA · Founded 2021 · Privately Held (backing)
Developer of transformative precision medicines intended to treat cancer and other serious conditions. Treeline Biosciences is based in Watertown, MA and was founded in 2021. It is valued at about $1.3 billion as of Oct 2026, set by institutional fund marks. It has raised $1.1 billion across 2 recorded rounds; the latest was a $200 million later-stage round in Aug 2025.
PMV mark · valuation
$1.3B
Oct 2026
Priced at
—
Total raised
$1.1B
Last round
Later Stage VC
Aug 2025
Cap table — not yet on record
Treeline Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Where does Treeline Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Treeline Biosciences's 2 recorded funding rounds.
